Product Information

CAS No.	509092-16-4
Product Name	Mocravimod

Biological Targets

S1PR1

Associated Conditions

lymphoid neoplasm·ulcerative colitis·hematopoietic and lymphoid system neoplasm·cutaneous lupus erythematosus

* The information provided here is compiled from public sources and is for reference only.

Studies related to this compound and its mechanism of action

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis.

Inflammatory intestinal diseases • Vol. 5, Issue 4 • 2020

PMID: 33313070 PMC: PMC7706482 DOI: 10.1159/000509393

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020

PMID: 32020584 PMC: PMC7160657 DOI: 10.1111/imm.13175

Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.

Transplantation • Vol. 82, Issue 6 • 2006

PMID: 17006328 DOI: 10.1097/01.tp.0000232687.78242.cd

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Circulation • Vol. 111, Issue 2 • 2005

PMID: 15642767 DOI: 10.1161/01.CIR.0000152101.41037.AB

Mocravimod

CAS No.	509092-16-4
MDL No.	N/A
MF	C₂₄H₂₆ClNO₃S
MW	444.00
InChI Key	IINUNQPYJGJCJI-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	509092-16-4
Product Name	Mocravimod

Biological Targets

S1PR1

Associated Conditions

lymphoid neoplasm·ulcerative colitis·hematopoietic and lymphoid system neoplasm·cutaneous lupus erythematosus

* The information provided here is compiled from public sources and is for reference only.

Mocravimod

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Mocravimod

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Mocravimod

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Similar Products

1,3-Propanediol, 2-amino-2-(2-(2-chloro-4-((3-(phenylmethoxy)phenyl)thio)phenyl)ethyl)-, hydrochloride (1:1)

Mocravimod

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Similar Products

1,3-Propanediol, 2-amino-2-(2-(2-chloro-4-((3-(phenylmethoxy)phenyl)thio)phenyl)ethyl)-, hydrochloride (1:1)

Documentation